LDL yielding an unstable complex which is dissociable with University of Graz, Harrachgasse 21/III and 2 Institute of Organic Chemistry, Lys analogues, proline and other charged molecules (Frank University of Graz, Heinrichstrasse 28, 8010 Graz, Austria et al., 1995). In the second step, the complex is stabilized by 3 To whom correspondence should be addressed.
incubated at 37°C with agitation (250 r.p.m.) until the culture immediately after purification (see Results) in modified cleavachieved an A 600 nm of 0.5. At this point the expression of age buffer (20 mM Tris-HCl, 100 mM NaCl, 50 mM imidazole, recombinant apo(a) KIV-T6 was induced by addition of 0.05 1 mM CaCl 2 , final pH 8.0). A ratio of 5 units of factor Xa mM isopropyl-β-D-thiogalactoside (IPTG) (Sigma) and the per milligram of recombinant protein was used and the mixture culture was incubated for an additional 4 h. During this time, was gently stirred at 25°C for 16 h. To monitor the cleavage A 600 nm reached~1.0 and~1.9 for induced and non-induced efficiency, the mobility shift of KIV-T6 was followed by SDScultures, respectively. Cells were harvested by centrifugation PAGE and immunoblotting. at 6000 g for 10 min at 4°C and the cell pellets were frozen SDS-PAGE and immunoblot analysis at -70°C until use. Approximately 2 g of cells were obtained Aliquots of cell lysates and fractions containing KIV-T6 were per liter of culture medium. Aliquots from induced and nonmixed with sample buffer [20% (w/v) glycerol, 5% (w/v) SDS, induced cells were taken, frozen at -20°C and analyzed by 0.15% (w/v) bromophenol blue, 63 mmol/l Tris-HCl, pH 6.8] sodium dodecyl sulfate polyacrylamide gel electrophoresis and incubated for 10 min at 95°C. Samples were analyzed by (SDS-PAGE), followed by Coomassie Brilliant Blue staining SDS-PAGE (15%) for 1 h at 150 V (running buffer: 25 mM in order to visualize protein bands.
Tris, 0.2 M glycine, 3.5 mM SDS) and protein bands were Cell fractionation visualized by Coomassie Brilliant Blue staining for 30 min. After thawing, the cell pellet from 1 l of culture was resusIn some cases samples were transferred to nitrocellulose pended in 50 ml of lysis buffer [(20 mM Tris-HCl, 100 mM membranes and incubated with a specific antibody against NaCl, 8 M urea (Sigma), 200 µl of 5 mg/ml DNase I (Sigma), KIV-T6 (see below). Bands were visualized by enhanced final pH 8.0] and this suspension was gently stirred for 30 chemiluminescence assay (ECL, Amersham) following the min on the turn-wheel (100 r.p.m.) at room temperature. To original protocol. reduce viscosity, the suspension was additionally passed
The specific polyclonal antibody against KIV-T6 was prethrough A 21-gauge syringe needle and finally centrifuged at pared by immunizing rabbits with three 500 µg portions of 12 000 g for 15 min at 4°C. The supernatant was used for KIV-T6 for 3 weeks. A 50 ml volume of blood was then further purification of apo(a) KIV-T6.
collected and centrifuged at 1500 g for 15 min at room temperature and plasma was treated with 600 mg/l of CaCl 2 Purification of recombinant apo(a) to eliminate fibrin. After 1 h of incubation at room temperature The purification of KIV-T6 was a combination of batch/gravity the sample was centrifuged at 45 000 g for 10 min; the flow column. TALON metal affinity chromatography is based supernatant was collected, supplemented with 1 mg/ml EDTA on the affinity of TALON for His-tagged recombinant protein and 1 mg/ml NaN 3 and stored at -20°C in small aliquots. An (Clontech). TALON resin was thoroughly resuspended, an antiserum dilution of 1:500 was found to be optimal for aliquot (2 ml of resin suspension per 5 mg of anticipated Hisimmunoblotting. tagged protein) was briefly centrifuged at 700 g for 2 min at room temperature to pellet the resin, the supernatant was
Refolding of KIV-T6 discarded and the resin was additionally washed with three This was performed as described (Buchner and Rudolph, 1991 ; volumes of lysis buffer as described in the original protocol LoGrasso et al., 1994) . After exchange of elution buffer (Clontech). Cell supernatant after cell fractionation was added by ultrafiltration (Amicon membrane, YM3 ϭ 3000 MW), to the resin and the suspension was gently stirred for 30 min recombinant protein from 1 l of E.coli culture was resuspended on the turn-wheel (60 r.p.m.) at room temperature. The sample in 3 ml of buffer A [100 mM Tris-HCl, 6 M guanidine-HCl was centrifuged at 700 g for 5 min at room temperature and (Sigma), 1 mM EDTA, 0.1 M DTT (Sigma), final pH 8.0] and the supernatant was discarded. The resin-protein complex was stirred (40 r.p.m.) at room temperature for 2 h. This solution washed twice with 30 ml of lysis buffer, followed by incubation was diluted with buffer B [100 mM Tris-HCl, 0.4 M arginine for 10 min at room temperature and centrifugation at 700 g (Sigma), 1 mM EDTA, 4 mM oxidized glutathione (Sigma), for 5 min each time. The resin-protein complex was transferred final pH 8.0] to 100 ml and incubated at 10°C for 5 days. into the column (5ϫ50 mm) and washed three more times Samples were stored at -20°C until further use. using 20 ml of wash buffer lacking urea (20 mM Tris-HCl, Reversed-phase high-performance liquid chromatographic 100 mM NaCl, 10 mM imidazole, final pH 8.0) in order to (RP-HPLC) analysis remove traces of urea and non-specific proteins. Finally, apo(a) RP-HPLC was carried out on a Hewlett-Packard Series 1050 KIV-T6 was eluted with elution buffer (20 mM Tris-HCl, 100 liquid chromatograph equipped with a 125ϫ4 mm Vydac mM NaCl, 50 mM imidazole, 1 mM CaCl 2 , final pH 7.5) at RP-4 column. A water-acetonitrile gradient, with acetonitrile a flow-rate of 0.5 ml/min. Protein was monitored at 280 nm concentration increasing from 10 to 90% in 60 min, was and 0.5 ml fractions were collected. Proteolytic cleavage of applied at a flow-rate of 1 ml/min. Both gradient compounds purified His-tagged KIV-T6 was performed immediately after were supplemented with 0.1% trifluoroacetic acid (TFA). The purification (see Results).
UV absorbance was measured at 215 nm. To confirm the proper kringle structure after refolding, the 1 H-NMR spectroscopy KIV-T6 was applied on a Lys-Sepharose 4B column (Pharmacia One-dimensional 1 H-NMR spectra were recorded at 27°C, Biotech) followed by a wash with wash buffer A (50 mM using a Varian 600 MHz Inova Unity spectrometer. The NMR Tris-HCl, pH 8.0) and twice with wash buffer B (50 mM sample contained 0.1 mM of human apo(a) KIV-T6 in 15 mM Tris-HCl, 0.5 M NaCl, pH 8.0). Protein was eluted with sodium phosphate buffer, pH 7.4, supplemented with 5% D 2 O. elution buffer [50 mM Tris-HCl, 0.2 M ε-aminocaproic acid Chemical shifts are reported in p.p.m. relative to the HOD (ε-ACA), pH 8.0] at a flow-rate of 1 ml/min and 1.0 ml resonance. fractions were collected.
I labeling of KIV-T6 Proteolytic cleavage
After purification and refolding, 2 mg of KIV-T6 were dialyzed For removal of the His-tag, recombinant His-tagged KIV-T6 was treated with factor Xa. Cleavage was performed against PBS (phosphate-buffered saline, pH 7.4) and finally coli cells containing the pT7-7/KIV-T6. Vector pT7-7 apo(a) KIV-T6 contains a T7 promoter, a 5Ј-polyhistidine T6 construct were induced at A 600 nm ϭ 0.5 with 0.05 mM IPTG. Aliquots tag, Xa restriction site followed by 318 bp coding sequence of apo(a) KIVof 1 ml were taken at the defined time points and centrifuged and cell T6 and two stop codons.
pellets were lysed with SDS loading buffer. An equal mass of protein was applied to each lane. Electrophoresis was carried out using 15% SDS-PAGE and visualized by Coomassie Brilliant Blue staining. Lanes 1-7 contain incubated with 1.0 mCi of 125 I for 5 min at room temperature.
aliquots of cell lysates induced for 0, 1, 2, 3, 4, 6 and 7 h, respectively.
In order to separate labeled protein from free 125 I, the sample Lane 8 contains lysozyme as a molecular marker of 14 kDa; the 16 kDa was chromatographed on a Sephadex G25M column followed band of KIV-T6 is marked with an arrow.
by dialysis against 15 l of PBS for 14 h at 4°C. The final protein concentration as determined by the Lowry method for the particular batch was 1.82 mg/ml. The specific activity measured in a γ-counter (Cobra Quantum-Packard) was 238 the pT7-7 vector was amplified in DH5-α E. concentrations (0.4, 0.1, 0.05 and 0.02 mM) were tested; 125 I-labeled KIV-T6 was incubated for 1 h with 2 ml of Lysresults are presented in Figure 2A . The optimal IPTG concenSepharose at room temperature. After filling into a small tration was found to be 0.05 mM and was used for induction column, the Lys-Sepharose was washed once with 4 ml of during further time-course and scale-up experiments. The time-PBS, twice with 4 ml of 40 mM NaCl and additionally twice course experiment for expression of apo(a) KIV-T6 is presented with 4 ml of PBS in order to remove NaCl. Elution was in Figure 2B . BL-21 (DE3) cells which had not been induced performed with increasing concentrations (0.2, 0.4, 0.6, 0.8, with IPTG showed no detectable expression of the 16 kDa 1.0, 1.4, 1.8 and 2.2 mM) of ε-ACA. Fractions of 4 ml were apo(a) KIV-T6 protein band. After induction with IPTG, cells collected and the protein concentrations were determined by were harvested at different time points and total bacterial measuring the radioactivity.
proteins were fractionated by SDS-PAGE (15%) followed by In order to study the affinity for LDL, refolded KIV-T6 was Coomassie Brilliant Blue staining. As shown in Figure 2A subjected to competition experiments for Lp(a) assembly. LDL and B, the pattern of total bacterial protein changed significantly was purified from healthy volunteers as described previously after induction. A time-dependent increase in expression of (Frank and Kostner, 1997) . Amounts of 2 µg of human LDL 16 kDa recombinant protein was observed. The best relation were incubated with the recombinant apo(a) 'XL' (Frank et al., between recombinant protein and total cell proteins was 1994) expressed in transiently transfected COS-7 with the observed 4 h after induction. admixture of various ratios of refolded KIV-T6 in DMEM medium, for 16 h at 37°C. The total reaction volume was 300
Purification of His-tagged apo(a) KIV-T6 µl. The amount of apo(a) XL complexed to LDL (assembly We examined various fractions of E.coli cells for the presence rate) was determined by a DELFIA immunoassay, as described of KIV-T6 in order to determine the subcellular distribution previously (Frank et al., 1999) .
of recombinant protein (data not shown). As reported previously for plasminogen and for other apo(a) kringles (Cleary Results et al., 1989; LoGrasso et al., 1994; Chung et al., 1998) , most PCR cloning and expression of apo(a) of the expressed KIV-T6 was present as insoluble protein in inclusion bodies. To obtain pure KIV-T6, inclusion bodies The cDNA for recombinant KIV-T6 was engineered by PCR were solubilized with lysis buffer containing 8 M urea (see in such a way as to contain two specific restriction sites Materials and methods) and recombinant apo(a) KIV-T6 was (EcoRI/HindIII) for insertion into the E.coli expression vector. isolated using TALON metal affinity chromatography. All The steps involved in this procedure are summarized in Figure  proteins lacking His6-tag were eluted in the few wash steps, 1. Additionally, a His6-tag and an Xa-cleavage site were added whereas apo(a) KIV-T6 remained bound to the column until to the N-terminus to simplify purification of recombinant elution with imidazole-containing elution buffer ( Figure 3A ). protein and the possibility of proteolytic removal of the His6- Figure 3B shows that the scale-up isolation in a one-step tag. The remaining three amino acids which precede the first purification is very efficient, resulting in high purity (Ͼ95%) histidine encoded by pT7-7 bacterial vector are Met-Ala-Arg.
of human apo(a) KIV-T6. The solubility of pure KIV-T6 in The calculated molecular weight of the whole recombinant Tris-HCl, pH 8.0, was Ͼ10 mg/ml. In 10 mM HEPES buffer, protein was 15.9 kDa.
The recombinant human apo(a) KIV-T6 cDNA inserted into pH 7.0, the solubility decreased to~8 mg/ml. SDS-PAGE (15%) under reduced (lines 2 and 3: 10 and 20 µg, respectively) and non-reduced conditions (line 4).
Fig. 4.
Factor Xa-protease digestion of His-tagged recombinant apo(a) KIV-T6. Purified KIV-T6 was digested with factor Xa as described under Materials and methods. After 16 h of digestion cleaved KIV-T6 (~70%) was separated by TALON affinity chromatography from non-digested protein and subjected to 15% SDS-PAGE followed by immunoblotting using a specific antiserum against KIV-T6. 1 ϭ KIV-T6 before cleavage; 2 and 3 ϭ two different concentrations of KIV-T6 after Xa-protease cleavage and separation by TALON affinity chromatography.
Proteolytic cleavage of recombinant protein
In order to remove N-terminal His6-tag from KIV-T6, proteolytic cleavage was performed with factor Xa. This protease between the His6-tag and the KIV-T6 sequences. We noticed eluted with a water-acetonitrile gradient (see Materials and methods). The that in our case the proteolytic cleavage was inefficient using y-axis displays the absorbance at 215 nm in milli-arbitrary units. The major peak comprised 99.11%. In addition, a small impurity comprising 0.89% of cleavage buffer recommended by Pharmacia Biotech (50 mM the peak area was also detected.
Tris-HCl, 100 mM NaCl, 1 mM CaCl 2 , pH 7.5). This was the case especially for the fractions which were stored at -20°C for more than 48 h and we presumed that this is caused by obtain a native kringle structure. As measures of proper kringle folding, four different methods were applied: binding to Lysmasking of the Xa cleavage site due to formation of intra-or inter-kringle accidental disulfide bonds during the protein Sepharose ( Figure 5A ), SDS-PAGE, RP-HPLC and 1 H-NMR spectroscopy. Figure 5B shows the SDS-PAGE pattern of the storage. In order to avoid this, we prepared cleavage immediately after purification through the TALON column. After identical sample once under reducing and once under nonreducing conditions; the non-reduced fraction migrated faster loading, the column was washed with buffer containing 8 M urea in order to remove non-specific proteins. Three additional than the reduced fraction owing to its compact kringle structure after refolding. wash steps followed using wash buffer without urea in order to remove traces of urea from the column. Finally, the cleavage RP-HPLC was applied to detect whether major fractions of unfolded or misfolded protein, which would cause different was performed immediately after elution in the elution buffer with addition of 1 mM CaCl 2 and factor Xa in the absence of retention behavior on an RP column, are present in the purified protein.
A sample of 150 µg of purified apo(a) KIV-T6 was urea. These modifications of cleavage procedure were necessary to increase the cleavage efficiency and they enabled us applied to the column. As displayed in Figure 6 , Ͼ99% of the protein eluted from HPLC column as one sharp and symmetto obtain His-tag free KIV-T6 with a yield of~70%. The cleavage efficiency was determined by SDS-PAGE and rical peak. A minor fraction comprising 0.89% was also observed. immunoblotting, yielding a shift in electrophoretic mobility which corresponds to a molecular size shift of~1.8 kDa 1 H-NMR analysis of refolded protein (Figure 4) .
Purified refolded human apo(a) KIV-T6 was investigated by Refolding of recombinant KIV-T6
1 H-NMR spectroscopy to verify the correct folding. Several investigators have demonstrated in the past the appearance of As the purification of recombinant apo(a) KIV-T6 from E.coli requires denaturing conditions, refolding was necessary to proton resonances at~0.2 and -1.0 p.p.m., which were consid- Fig. 9 . KIV-T6 inhibition of Lp(a) assembly. Purified human LDL (2 µg) was incubated with recombinant apo(a)-XL (containing 18 KIV repeats as described by Frank et al., 1994) in the presence of refolded KIV-T6 at molar ratios of 1:1 to 1:1000 in 300 µl of DMEM medium for 16 h at 37°C. The rate of assembly was determined by DELFIA as described by Frank et al. (1999) . The values are means of three measurements.
fold molar excess the inhibition was not more than 60% compared with the assembly in the absence of KIV-T6.
Discussion
The results of the present study demonstrate that human apo(a) KIV-T6 can be expressed in the E.coli system, purified and properly refolded in vitro. Overexpression of KIV-T6 as a His6-tagged protein in E.coli could be achieved under control of the T7 promoter. The kind of promoter seems to play a promoter, which is known as a very strong promoter for bacterial expression, yielded only very small amounts of KIV-T6 (data not shown). This seems to be a general phenomenon ered as fingerprints for a proper kringle folding (DeMarco for expressing kringles in bacterial systems as an identical et al., 1982; Trexler et al., 1983; Ramesh et al., 1987;  Thewes observation was made previously by LoGrasso et al. (1994 LoGrasso et al. ( ), et al., 1987 . These resonances arise from the δ,δ 1 -CH 3 protons who expressed the apo(a) kringle T10. The amount of expressed of the conserved Leu46 residue by interaction with several protein under control of the T7 promoter was generally high. ring currents caused by aromatic amino acid residues (DeMarco After purification and refolding amounts in the region of 7 mg et al., 1985) . This fact has also been used previously to of KIV-T6 per liter of culture medium were obtained. This is provide evidence for a proper refolding of recombinant human 10-15 times higher than the amount of tissue plasminogen plasminogen kringle I (Menhart et al., 1991) and human activator (t-PA) K-2 expressed (Cleary et al., 1989) . Other apolipoprotein(a) kringle 37 (LoGrasso et al., 1994) . The highgroups (Menhart et al., 1991; Li et al., 1992) reported on the field region of a one-dimensional 1 H-NMR spectrum is shown expression of different plasminogen kringles in E.coli achieving in Figure 7 . Resonances observed at 0.20, 0.15 and -1.05 up to~200 µg/l culture medium. These experiments were p.p.m., respectively, in our case also demonstrated a proper performed under control of the tac promoter or the alkaline structure of the refolded apo(a) KIV-T6.
phosphate (AP) promoter, which appear to be less suitable Binding of 125 I-labeled apo(a) KIV-T6 to Lys-Sepharose for the expression of apo(a) kringle domains. However, the In order to study the binding affinity of KIV-T6 to surfacepossibility that the KIV-T6 cDNA sequence could also play a bound Lys, 125 I-labeled protein in PBS, pH 7.4, was incubated very important role for the expression still exists and cannot with Lys-Sepharose and specifically bound material was eluted be excluded. with increasing concentrations of ε-ACA ranging from 0.2 to
The homogeneity of refolded and purified apo(a) KIV-T6 2.2 mM. By semilogarithmically plotting the fraction of bound was assessed by RP-HPLC, showing a single peak and Ͼ99% KIV-T6 versus the ε-ACA concentration, an EC 50 value of purity. Furthermore, our purified and refolded KIV-T6 was 0.47 mM was obtained (Figure 8) .
studied by 1 H-NMR spectroscopy and exhibited methyl doublet Inhibition of Lp(a) assembly by signals at 0.2 and -1.05 p.p.m., an important measure of proper kringle folding (DeMarco et al., 1982 (DeMarco et al., , 1985 Ramesh et al., In order to investigate the extent to which refolded KIV-T6 might be able to interfere with the Lp(a) assembly using LDL 1987; Thewes et al., 1987) . These signals arise from the protons of the δ,δ 1 -CH 3 groups of Leu45 and are a strong and an intact recombinant apo(a) containing 18 KIV repeats, KV and the protease domain, apo(a)-XL was incubated with argument for the integrity of the folding of KIV-T6. This was further confirmed by the demonstration that purified and LDL in the absence and presence of increasing amounts of KIV-T6. As shown in Figure 9 , a 100-fold molar excess of refolded apo(a) KIV-T6 bind to Lys-Sepharose. However, LysSepharose binding of KIV-T6 was only approximately four KIV-T6 inhibited Lp(a) assembly by only~20%. At a 1000-times weaker than that of the previously described recombinant Thewes,T., Ramesh,V., Simplaceanu,E.L. and Llinas,M. (1987) Biochim. apo(a) showing the weakest lysine binding affinity (Frank and Biophys. Acta, 912, 254-269. Kostner, 1997 conditions where KIV-T6 had an EC 50 value of 0.47 mM. This Utermann,G. (1989) Science, 246, 904-910. is in line with previous observations that the binding affinity Utermann,G. (1990) Curr. Opin. Lipidol., 1, 404-410. of recombinant apo(a) correlates positively with the number White,A.L. and Lanford,R.E. (1994) J.Biol.Chem., 269, 28716-28723. of kringles with lysine binding affinity (Frank and Kostner, Received February 11, 2000; revised July 24, 2000; accepted August 10, 2000 1997). Our original intention was to investigate the interaction of KIV-T6 with LDL and to map the binding to surface structures of apoB 100 in order to obtain further information on the mode of Lp(a) assembly. However, the binding affinity of this single kringle to LDL under physiological conditions was very low (K d Ͼ 10 -3 M) (data not shown). In competition experiments using LDL and intact recombinant apo(a) the relatively low affinity of the single kringle KIV-T6 was further underlined: At a 1000-fold molar excess this kringle inhibited only about 60% of the Lp(a) assembly. These findings suggest that the first step of Lp(a) assembly is more complex than simple interaction of apo(a) with Lys residues on the LDL surface. In line with this assumption is the fact that Lp(a) assembly is inhibited not only with Lys analogues but also with Pro and hydroxy-Pro (McConathy and Trieu, 1991; Frank and Kostner, 1997) .
The availability of large amounts of pure native apo(a) KIV-T6 should enable us to perform further functional assembly studies. In addition, KIV-T6 is currently crystallized and its structure will be studied by X-ray crystallography.
